Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Discover various wealth accumulation methods and strategies to enhance your financial growth. Start implementing them now.
28,655 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Oracle shares have fallen sharply as investors reassess AI-related capital expenditure. This piece compares Oracle’s ...
On Thursday, Vertex stock surged nearly 6% after a positive analyst note. This guide breaks down what drove the move,...
Oil hits $106 per barrel as Hormuz remains a flashpoint. The U.S. and NATO politics add to volatility while investors...
Ripple breaks into a rare league of private unicorns, joining SpaceX and OpenAI. XRP trades around $1.40 as investors...
OP Labs reports a turning point for crypto monetization as exchange-owned stack chains made a near-$500 million oncha...
Ethereum appears to hold a clearer path for near-term traders, while Ripple’s XRP may deliver stronger gains for thos...
Roundhill’s WEEK ETF is gaining attention for delivering regular weekly distributions from short-term U.S. Treasuries...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
AMZY, the YieldMax AMZN Option Income Strategy ETF, uses a synthetic covered-call approach to generate monthly distri...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
A little-known ETF with amplified crude exposure has jumped 289% year-to-date as oil holds near $80, highlighting the...